Blackmores profit falls 10%

Vitamins and supplements supplier hit by falling Australian margins

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Increased competition and structural changes in the pharmacy sector have hit Blackmores' (ASX:BKL) annual results, with net profit after tax falling 10% to $25 million.

Despite strong sales results of $327 million, up 25% over the previous financial year, Blackmores was hit by a decline in its Australian margins. Net debt more than doubled to $69 million, resulting in higher interest expense, and interest cover dropping from 15.2 times to 8.1 times.

Smaller community pharmacies are declining as larger discount 'warehouse' style pharmacies pop up, intense competition from other brands such as Swisse, and pressure from the big supermarket retailers Woolworths (ASX:WOW), Coles – owned by Wesfarmers (ASX:WES) and Metcash (ASX:MTS) backed IGA stores are all playing a part in cutting Blackmores margins.

And Blackmores says these market dynamics are likely to persist in the coming year, making its strategy of expanding into Asian markets all the more important. Despite Blackmores declaring a final dividend of 83 cents, fully franked, as a vote of confidence in the company's future, this is a company under pressure, and will have to run hard just to stand still.

Asia remains the key to future growth, as the Australian market goes through structural changes. Blackmores has established operations in China, Thailand, Malaysia, Hong Kong, Singapore and Taiwan, which all achieved record sales. During the year Blackmores launched in Macau and China, and expects to see sales grow in the coming year.

Foolish takeaway

Blackmores is a company under pressure to revive its profit growth, despite strong sales growth. The acquisition of BioCeuticals, a practitioner-only supplements supplier, is expected to continue to provide a positive contribution to earnings, and Blackmores expects an improvement in profit in 2014. Foolish investors may want to wait and see how the year ahead pans out, before making an investment in Blackmores.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool writer/analyst Mike King owns shares in Woolworths.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »